Search research articles
Contact Us
Filters
Showing results (11-20 of 35) with videos related to
Page
of 4
Sort By:
Blood
|
November 17, 2011
Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells
Sergey Krysov, Samantha Dias, Alex Paterson, et al.
Clinical Immunology (Orlando, Fla.)
|
July 23, 2016
Precision treatment with sirolimus in a case of activated phosphoinositide 3-kinase δ syndrome
William Rae, Kesava A Ramakrishnan, Yifang Gao, et al.
Clinical and Experimental Immunology
|
January 13, 2026
CD40L and IL-4 Lymph Node-Associated Signals Protect B Cells from Rituximab-Induced ADCC via KIR and NKG2A
Lara V Graham, Russell B Foxall, Margaret Ashton-Key, et al.
Oncotarget
|
March 10, 2016
A combination of trastuzumab and BAG-1 inhibition synergistically targets HER2 positive breast cancer cells
Emmanouil Papadakis, Natalia Robson, Alison Yeomans, et al.
Oncotarget
|
June 21, 2015
Annexin A3 is a mammary marker and a potential neoplastic breast cell therapeutic target
Bashar Zeidan, Thomas R Jackson, Samantha E T Larkin, et al.
Histochemistry and Cell Biology
|
December 14, 2021
Alternative tissue fixation for combined histopathological and molecular analysis in a clinically representative setting
Amelia Meecham, Elena Miranda, Hayley T Morris, et al.
Scientific Reports
|
October 8, 2020
Immune characterization of pre-clinical murine models of neuroblastoma
Emily R Webb, Silvia Lanati, Carol Wareham, et al.
Haematologica
|
April 21, 2018
Novel <i>GPR34</i> and <i>CCR6</i> mutation and distinct genetic profiles in MALT lymphomas of different sites
Sarah Moody, Joe Sneath Thompson, Shih-Sung Chuang, et al.
Blood
|
August 30, 2014
Stimulation of surface IgM of chronic lymphocytic leukemia cells induces an unfolded protein response dependent on BTK and SYK
Sergey Krysov, Andrew J Steele, Vania Coelho, et al.
Scientific Reports
|
May 24, 2022
Prognostic significance of crown-like structures to trastuzumab response in patients with primary invasive HER2 + breast carcinoma
Charles N Birts, Constantinos Savva, Stéphanie A Laversin, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 35) with videos related to
Sort By:
Page
of 4
Blood
|
November 17, 2011
Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells
Sergey Krysov, Samantha Dias, Alex Paterson, et al.
Clinical Immunology (Orlando, Fla.)
|
July 23, 2016
Precision treatment with sirolimus in a case of activated phosphoinositide 3-kinase δ syndrome
William Rae, Kesava A Ramakrishnan, Yifang Gao, et al.
Clinical and Experimental Immunology
|
January 13, 2026
CD40L and IL-4 Lymph Node-Associated Signals Protect B Cells from Rituximab-Induced ADCC via KIR and NKG2A
Lara V Graham, Russell B Foxall, Margaret Ashton-Key, et al.
Oncotarget
|
March 10, 2016
A combination of trastuzumab and BAG-1 inhibition synergistically targets HER2 positive breast cancer cells
Emmanouil Papadakis, Natalia Robson, Alison Yeomans, et al.
Oncotarget
|
June 21, 2015
Annexin A3 is a mammary marker and a potential neoplastic breast cell therapeutic target
Bashar Zeidan, Thomas R Jackson, Samantha E T Larkin, et al.
Histochemistry and Cell Biology
|
December 14, 2021
Alternative tissue fixation for combined histopathological and molecular analysis in a clinically representative setting
Amelia Meecham, Elena Miranda, Hayley T Morris, et al.
Scientific Reports
|
October 8, 2020
Immune characterization of pre-clinical murine models of neuroblastoma
Emily R Webb, Silvia Lanati, Carol Wareham, et al.
Haematologica
|
April 21, 2018
Novel <i>GPR34</i> and <i>CCR6</i> mutation and distinct genetic profiles in MALT lymphomas of different sites
Sarah Moody, Joe Sneath Thompson, Shih-Sung Chuang, et al.
Blood
|
August 30, 2014
Stimulation of surface IgM of chronic lymphocytic leukemia cells induces an unfolded protein response dependent on BTK and SYK
Sergey Krysov, Andrew J Steele, Vania Coelho, et al.
Scientific Reports
|
May 24, 2022
Prognostic significance of crown-like structures to trastuzumab response in patients with primary invasive HER2 + breast carcinoma
Charles N Birts, Constantinos Savva, Stéphanie A Laversin, et al.
Page
of 4